Skip to main content
. 2011 Jun 21;27(3):152–156. doi: 10.1007/s12288-011-0080-4

Table 3.

The clinical findings based on which the results of the study is recorded

Case no. Age/Sex Day 1 Follow up one month Follow up 2 months Follow up 3 months Results %
A B C A B C A B C A B C
1 52/F 8 II Absent 6 II Absent 3 III Absent 0 IV Absent 100
2 50/F 7 II Absent 6 II Absent 2 III Absent 0 IV Absent 100
3 14/F 8 II Present 5 III Absent 2 IV Absent 0 IV Absent 100
4 50/F 10 I Present 9 I Present 6 III Absent 0 IV Absent 100
5 49/F 10 II Present 8 II Reduced 4 III Absent 0 IV Absent 100
6 39/M 9 II Present 7 II Reduced 3 III Reduced 0 IV Absent 100
7 65/M 10 I Present 10 I Present 10 I Present 10 I Present 0
8 50/F 10 II Present 10 II Present 10 I Present 10 I Present 0

A Visual analogue score as observed from day one to follow up for 3 months

B Grade of mobility

C Presence of Swelling and/or redness at the site of tendinopathy